Half of Baby Boomers Spend More Than Three Hours on Their Phones Daily
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Half of baby boomers are spending more than three hours on their phones each day, according to a new survey from AddictionResource.net.
The older age cohort, which includes ages 61 to 79, showed signs of potential digital addiction despite stereotypes that phone and social media overuse mainly impacts younger age groups.
Why It Matters
The report from AddictionResource.net found that 50 percent of their mostly baby boomer sample reported spending more than three hours daily on their smartphones. Roughly 20 percent spent more than five hours per day.
Adults are recommended to limit their recreational screen time to less than two hours per day, according to AddictionResource.net.
A report from AddictionResource.net found that 50 percent of their mostly baby boomer sample reported spending more than three hours daily on their smartphones.
A report from AddictionResource.net found that 50 percent of their mostly baby boomer sample reported spending more than three hours daily on their smartphones.What To Know
A 2024 study from Pew Research discovered that nearly half of American teens are online "almost constantly," but that behavior isn't limited to young Americans.
While baby boomers grew up without cellphones and the internet, they have a high usage rate of cellular devices in their golden years.
The AddictionResource.net survey was based on responses from 2,000 people ages 59 to 77, making the majority of respondents baby boomers. Of that group, 40 percent said they felt anxious or uncomfortable when they don't have access to their digital devices. And 50 percent said they check their phone within an hour of waking up every day.
What People Are Saying
HR consultant and generational expert Bryan Driscoll told Newsweek: "Boomers spend hours glued to their phones, but it's not connection—it's isolation. Many struggle to separate fact from fiction online, making them more vulnerable to misinformation and digital echo chambers. This isn't just about screen time, it's about a generation grappling with loneliness and a shifting sense of what's real."
Ruth Hernandez, a mental health counselor at AddictionResource.net, told Newsweek: "Honestly, it's not that surprising anymore to see baby boomers spending hours on their phones. Many of them use smartphones for everything these days, such as texting with family, managing their health apps, reading the news, staying in touch on social media, and even streaming shows or watching videos. It's become part of their daily routine, just like it is for younger folks."
What Happens Next
The findings of the survey indicate that digital addiction is not a problem exclusive to younger generations, Hernandez said.
"This really pushes back on the old stereotype that older people aren't tech-savvy or don't care about digital life," she said. "The truth is, boomers have adapted, many of them pretty quickly, and in some cases, they're just as glued to their screens as the rest of us.
"At the end of the day, it shows that digital habits aren't tied to age anymore. They've become part of how we all live, work and connect. Whether you're 25 or 75, the pull of your phone is real."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
16 minutes ago
- Newsweek
Woman Spends Day in the Sea—Wakes Up Terrified by Her Own Reflection
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Paige Cudini was enjoying a birthday trip to San Diego when a seemingly normal day in the sun turned into a medical nightmare. The marketing manager, 25, who lives in Las Vegas, had grown up in the southern U.S. and was no stranger to sunlight—but what happened next left her stunned. "It was so shocking that 90 minutes in California changed my life forever," Cudini told Newsweek. Before heading out for her surfing lesson, Cudini applied sunscreen multiple times to her face and scalp—the only parts of her body exposed to the sun—believing this would be sufficient protection against its rays. From left: Cudini gives a thumbs-up while wearing a wet suit; and her face is seen swollen. From left: Cudini gives a thumbs-up while wearing a wet suit; and her face is seen swollen. TikTok/@ "While I was out, I did feel like I was burning a bit, but that wasn't anything out of the ordinary for me," Cudini said. "I had begun to see a bit of redness around dinner time, but it seemed like my typical burn, so I didn't pay too much attention to it." Cudini applied aloe vera before going to bed that evening, thinking it would reduce the redness. "As I was starting to fall asleep, I noticed I was shaking quite a bit and that I couldn't get warm for the life of me, but eventually I was able to fall asleep," Cudini said. "On July 7, that's when I realized something was wrong. "I woke up in pain and could barely open my eyes. I ran to the bathroom, looked in the mirror and realized my face was completely swollen." From left: Cudini poses with her face covered in aloe vera; and she puts her thumb up to show her smooth face after the skin peeled off. From left: Cudini poses with her face covered in aloe vera; and she puts her thumb up to show her smooth face after the skin peeled off. TikTok/@ Cudini has shared a series of photos on TikTok (@ where her eyes and nose appear to be puffy. Then, she starts to blister followed by losing the ability to open her left eye. She told Newsweek that her symptoms include shaking, swelling, and pain. On July 8, she was officially diagnosed with sun poisoning—a severe form of sunburn characterized by blisters, indicating a second-degree burn that can lead to serious complications—and was prescribed a 15-day course of Prednisone. "At this point, my pain was through the roof, and I was struggling to breathe through my nose because of the swelling," Cudini said. The side effects persisted for more than a week, including chills, nausea, headaches, blistering, dehydration, and even muscle stiffness. "Once the swelling had started to go down a bit, that's when the scabbing and peeling got me," Cudini said. "Whenever I tried to put on aloe vera or burn gel, my skin was coming off in chunks; I had no idea skin could even do this." "Honestly, I was terrified. I had such a hard time recognizing myself and even my Face ID stopped recognizing me," she added. "I was still working this entire time and could barely keep my eyes open, which was very unfortunate. "Waking up to my eyes being completely shut was the worst day of the entire sun-poisoning experience because I truly had no idea what to do. I was putting ice packs on my eyes, massaging my face to try to reduce swelling, elevating my head while I slept, and nothing seemed to be working." Despite the physical discomfort, Cudini said that finding humor in the situation helped her cope. "Throughout the 1.5 weeks, the one thing that kept my head above water was learning how to laugh at the situation. Because of my post, I've been so fortunate to hear other people's stories and really understand just how crazy an experience like this can change a person." "I'm fully black and literally got sun poisoning. It's not fun because it itches and burn at the same time. Then peels. USE Y'ALL SUNSCREEN NO MATTER YOUR RACE!!!!!" said one user on the video that has 2.2 million views. "This happened to me when I was 10—it's the worst pain and trauma of my life and needed to go to hospital when I got home from holiday. I really sympathize and hope you're ok, it's SO painful," posted another user. From left: Cudini smiles as her face has returned back to normal. From left: Cudini smiles as her face has returned back to normal. TikTok/@ Though she has now recovered, Cudini said the experience has radically changed her relationship with the sun. "I'm able to work in the office again and have taken some new preventive measures such as wearing sunglasses and a hat anywhere I go, switching to a mineral sunscreen, and waiting to go outside until the sun has gone down," she said. "I am still quite nervous to go back into the sun for a longer period of time, but I think that's something I'll just need to work up to moving forward."
Newsweek
19 minutes ago
- Newsweek
Emerging Treatment Could 'Significantly Improve' This Chronic Condition
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new study by the University of Virginia and Virginia Commonwealth University has found that a drug typically used in the treatment of heart failure has notable positive effects for patients with a common chronic illness. The drug ivabradine has been on the market for years as a medication for heart failure, but more recently has been found to help patients with Postural Orthostatic Tachycardia Syndrome (PoTS). Ivabradine became available in the U.S. about 10 years ago having previously been available in the U.K. and other countries, Dr. Svetlana Blitshteyn, professor of neurology at the University at Buffalo, told Newsweek. Commenting on ivabradine's use, Professor Lesley Kavi, the chairperson of the U.K.-based charity organization PoTS UK, told Newsweek that U.K.-based PoTS specialists "have a lot of experience of prescribing it." "It's often their first choice treatment if self management strategies are not sufficient and our experience as a charity is that patients find it very helpful," she added. Some U.S. doctors have been prescribing the drug to PoTS patients for a number of years, with other studies noting its positive effect on patients—with one finding the drug had an 88 percent improvement rate on symptoms. Other studies have found a marked improvement in symptoms for children with the condition, particularly an improvement on sudden losses of consciousness, lightheadedness and fatigue. Therefore, while the drug is not new, nor newly prescribed to PoTS patients, the two Virginia universities' study—published in the Journal of Cardiovascular Pharmacology in July—adds to a body of research revealing the largely positive impact the drug can have on PoTS symptoms. A file photo shows a medical professional monitoring a patient's heart rate. A file photo shows a medical professional monitoring a patient's heart Is PoTS? PoTS is understood as an abnormality in the functioning of the autonomic nervous system, the system controlling breathing, gut function, heart rate, blood pressure and many other bodily functions. It results in a wide range of symptoms, particularly when standing, such as increased heart rate, chest pain, hot flushes, nausea, dizziness, feeling faint, headaches, tunnel or blurred vision and more. As symptoms tend to persist when standing, the condition can have huge impacts on patients' lives, because many basic tasks require postural changes and standing. Why this happens for patients with PoTS is still under investigation, but mechanisms, such as "low blood volume, abnormal blood flow, hyperadrenergic state, immunologic changes and small fiber neuropathy, may be among the reasons," Blitshteyn said. Some research has also suggested PoTS is an autoimmune condition, Dr. Blair Grubb, a professor of medicine, pediatrics and neurology and director of the Cardiac Electrophysiology Program at the University of Toledo Medical Center, told Newsweek, adding it could be triggered by a viral infection. PoTS is believed to affect millions of Americans—although exact estimates vary widely, which some experts believe is because it is under-recognized. In the wake of the COVID pandemic, the condition has become more recognized as the prevalence of PoTS has been dramatically increasing. "Post-COVID, nationwide, the incidence of PoTS went up fivefold," Grubb said. While awareness is increasing, there is still a long way to go. "It's very unfortunate because these people are mistreated and ignored, and I think the real reason is many of them are women," he said. "If this was a disease principally in men it would be taken more seriously." "There is a real tendency in America to blame the patient for their illness and women are just ignored," he said, adding women were often passed off as being "hysterical" by some health care professionals. Additionally, there are also not enough doctors treating the condition, Dr. Satish Raj, a professor of cardiac sciences, director of the Calgary Autonomic Investigation and Management Clinic, and director of education at the Libin Cardiovascular Institute, told Newsweek. "Most specialized autonomic clinics have waiting lists of one year or more," he said. "These patients require a lot of time to understand the issues and to iteratively try treatments," he added. "Health insurance does not pay well for talking to and assessing complex patients—they pay for procedures. This is not a procedure-intensive problem." What The Study Found In an analysis of 10 patients with PoTS, researchers found that ivabradine reduced their heart rate while "significantly improving" other symptoms. The study revealed that participants' heart rate was significantly decreased after taking the drug—a change from a 40 beats per minute (bpm) increase on standing, to a 15 bpm increase. Other symptoms were also eased by the drug, with patients reporting the greatest improvement in "feeling faint," which decreased by 69 percent after taking ivabradine, and "chest pain," which decreased by 66 percent. The researchers said that the overall improvement in symptoms, via a reduction in heart rate, suggests that "the heart rate issue is an underlying driver of other PoTS symptoms." The patients involved in the study had an average age of 28, with an age range of 21 to 36, and eight of the 10 participants were women. Three of the cases followed a viral illness, with two following a COVID infection. While other drugs can reduce heart rate, the notable difference about ivabradine is that it does not affect a person's blood pressure. For PoTS patients, changes to blood pressure can exacerbate symptoms. An "uncontrolled heart rate can contribute significantly to different symptoms in PoTS, so lowering heart rate definitely helps with overall symptoms control," Raj said. He said that the lightheadedness and "feeling faint" that PoTS patients typically experience can "often be due to high heart rates and decreased filling time in the heart that can decrease blood flow," so lowering the heart rate can help with that—as well as easing symptoms like nausea, and occasionally headaches. Kavi said that, while it is not fully understood, "it is likely that reducing heart rate a little improves the ability of the heart to pump and maintain blood pressure and blood supply to organs, thereby reducing other symptoms too." What The Study Means For PoTS Treatment PoTS patients are often prescribed beta-blockers for symptom management, and while these drugs can reduce heart rate and have a positive impact for some patients, they can also affect blood pressure. This means that in some PoTS patients, beta-blockers can enhance dizziness and lightheadedness, as well as causing a number of other unwanted side effects. Ivabradine could therefore be an effective alternative medication for PoTS patients who do not respond well to beta-blockers. "Drugs like beta blockers can lower blood pressure and can make people feel lousy," Grubb said. "Beta blockers can make people feel depressed and terrible, but ivabradine lowers heart rate with no effect on blood pressure, so it's kind of the ideal drug." Grubb said he has been using ivabradine in his clinic for PoTS patients for a number of years. "It's an extremely valuable drug that we use, and it's actually become a first-line drug in treating our patients," he said. However, given their positive effect for some patients, "beta blockers continue to be the first choice for treatment of PoTS and other forms of dysautonomia, in my experience," Blitshteyn said. "Obviously, the more medications we have available for the treatment of PoTS, the better it is for patients," she said. Blitshteyn added that ivabradine is also one of the medications being looked at in terms of post-COVID PoTS in the NIH-RECOVER Autonomic trials, a research program aimed at investigating, diagnosing and treating long COVID. An Underrecognized Condition While ivabradine has been around for some time, it has been approved for heart failure and not for PoTS, Raj said. "It can be difficult for patients with PoTS to be able to get the medication approved by their insurance companies," he said, adding access is therefore "more limited than it should be." Additionally, "education of medical students and doctors on autonomic disorders, including PoTS, is still lacking," Blitshteyn said. As a result, PoTS can often be "misdiagnosed with anxiety, depression, panic disorder, anemia, dehydration and many others, so when a doctor doesn't know much about PoTS, they are most likely to misdiagnose it," Blitshteyn added. "Psychological labeling is common especially in women and PoTS is much more common in women," Kavi said. Doctors usually have limited time to spend with patients, Blitshteyn added, but patients with PoTS are "often complex, requiring time, effort, knowledge and understanding." Kavi said that, since the COVID pandemic, "there has been an increase in awareness of PoTS by healthcare professionals, so more people are being diagnosed, although they often still have tortuous journeys to obtain a diagnosis." "There is consequently more demand for specialist services but no significant increase in capacity," Kavi added.
Business Insider
19 minutes ago
- Business Insider
This startup offered ride-hailing for women years before Uber and Lyft — and its founder isn't shying away from the competition
Uber is starting to let women request women drivers. It's about time, says Jillian Anderson. Anderson founded HERide, which started offering rides in Atlanta in 2022 — three years before Uber announced last month that it would start allowing women to request female drivers on its app. Anderson said she got the idea for HERide while working as a ride-hailing driver herself. Many of the women Anderson picked up after dark told her that male drivers often asked to take the ride off-app or tried to get their contact information, she told Business Insider. "After hearing endless stories like that for a couple years, I was like, this sounds like a feature that Uber and Lyft could just create," Anderson said. "Why haven't they implemented anything like this?" Instead of waiting for the companies to act, Anderson said she started coding her own app, recruiting women drivers, and creating HERide as an alternative. Today, the app operates in Atlanta, including at Hartsfield—Jackson Atlanta International Airport, as well as nearby Athens, Georgia. While ride-hailing is nothing new for most Americans, apps like HERide — and Uber's newest feature, called "Women Preferences" — show one potential avenue for growth in the industry: Offering special rides and services to specific groups of people, from women to older people. Uber said in July that it would pilot its rides-for-women feature in a handful of cities. Already, the company offers rides for teens and a simplified version of the app for senior citizens. Lyft also has an option for women and nonbinary riders to request a woman driver. Besides women, HERide also markets its service to LGBTQ+ clients, DeVynne Starks, the company's cofounder and director of marketing and communications, told Business Insider. "We don't just want only women to be safe," she said. "We truly do want to enforce safer ride-sharing practices for everyone." With Uber unveiling its own rides-for-women feature, HERide is now betting that it will have an edge over its bigger competitors in the places where it operates. Anderson points to one advantage: HERide guarantees riders a woman driver. Uber, meanwhile, says that its Women Preferences feature "increases your chances of being matched with a woman driver," though "it's not guaranteed." Another is that HERide uses a rate card to determine its fares instead of fluctuating rates based on demand or an even more complicated model like Uber's upfront pricing, Anderson said. Before they ride, HERide's users can use a fare estimator widget that Anderson said she coded herself and added to the ride-hailing service's website. "It's probably the No. 1 question that we get before people actually download the app," she said about the price of rides. HERide drivers, meanwhile, get 80% of each fare for rides that they complete, though Anderson says that that will be closer to 70% in the future to make the company profitable. Some Uber and Lyft drivers have told Business Insider that they often get less than half of the fare that customers pay. Anderson said that she wants to retain drivers, including those who make ride-hailing their full-time job. "If we're paying them a fair wage, I believe that we'll stay competitive in the space," Anderson said.
